Campy Blood Free Selective (CCDA)
Manufacturer: Neogen Inc.
Starting at from $112.35 Sale $106.74
Select a product below and add it to your cart to request a quote.
Campy Blood Free Selective (CCDA)
Description
Acumedia | BD / Difco | BD / BBL | Oxoid | Merck |
Campy Bld Free Select Med (7527) | N/A | N/A | CM0739 + | 1.00070+ |
+ Supplement required.
Intended Use
Campy Blood-Free Selective Medium (CCDA) is used with Cefoperazone for the selective isolation of Campylobacter spp.
Product Summary and Explanation
Many experts consider Campylobacter to be the leading cause of enteric illness in the US. Campylobacter spp. can cause mild to severe diarrhea, with loose, watery stools often followed by bloody diarrhea. These pathogens are highly infective, and transmitted by contaminated food or water.
Campy Blood-Free Selective Medium (CCDA) was described by Bolton et al.2 This medium was formulated to replace blood with charcoal, ferrous sulfate, and sodium pyruvate. To improve selectivity, Cefoperazone replaced Cephazolin in the original formulation. Bolton recommended incubating inoculated plates at 37°C to improve isolation rates. Yeast and fungal contaminants are inhibited with the addition of amphotericin B.
Campy Blood-Free Selective Medium (CCDA) is recommended for food testing. Campy Blood-Free Selective Medium with the addition of Yeast Extract and Cefoperazone is used in the Isolation of Campylobacter species from Foods and Swabs in the FDA/BAM Method.